WO2011150939A1
(en)
|
2010-06-01 |
2011-12-08 |
Glycom A/S |
Polymorphs of 2'-o-fucosyllactose and producing thereof
|
JP2013531049A
(ja)
*
|
2010-07-16 |
2013-08-01 |
グリコム アー/エス |
オリゴ糖の誘導体化
|
MX338174B
(es)
*
|
2010-12-31 |
2016-04-06 |
Abbott Lab |
Metodos para reducir la incidencia de la tension oxidativa al usar los oligosacaridos de leche humana, la vitamina c y los agentes antiinflamatorios.
|
NZ612472A
(en)
|
2010-12-31 |
2015-02-27 |
Abbott Lab |
Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection
|
US9539269B2
(en)
|
2010-12-31 |
2017-01-10 |
Abbott Laboratories |
Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
|
NZ612455A
(en)
|
2010-12-31 |
2015-02-27 |
Abbott Lab |
Human milk oligosaccharides to promote growth of beneficial bacteria
|
EP3338784B1
(en)
|
2010-12-31 |
2020-07-22 |
Abbott Laboratories |
Human milk oligosaccharides for modulating inflammation
|
MY166945A
(en)
|
2010-12-31 |
2018-07-25 |
Abbott Lab |
Nutritional formulations including human milk oligosaccharides and long chain polyunsaturated polyunsaturated fatty acids and uses thereof
|
CN103391783A
(zh)
|
2010-12-31 |
2013-11-13 |
雅培制药有限公司 |
使用人乳寡糖改善呼吸道健康的方法
|
EP2678347A4
(en)
*
|
2011-02-21 |
2014-10-08 |
Glycom As |
CATALYTIC HYDROGENOLYSIS OF A COMPOSITION FROM A MIXTURE OF OLIGOSACCHARIDE PROBLEMS AND APPLICATIONS THEREOF
|
EP2686330A4
(en)
*
|
2011-03-18 |
2014-11-12 |
Glycom As |
SYNTHESIS OF NEW FUCOSE-CONTAINING CARBOHYDRATE DERIVATIVES
|
WO2012155916A1
(en)
*
|
2011-05-13 |
2012-11-22 |
Glycom A/S |
Manufacture of lacto-n-tetraose
|
EP2522232A1
(en)
*
|
2011-05-13 |
2012-11-14 |
Nestec S.A. |
Nutritional products comprising human milk oligosaccharides and methods for manufacture thereof
|
SG2014013478A
(en)
|
2011-08-29 |
2014-05-29 |
Abbott Lab |
Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
|
WO2013044928A1
(en)
*
|
2011-09-30 |
2013-04-04 |
Glycom A/S |
Synthesis of hmo core structures
|
US20140271562A1
(en)
|
2011-10-18 |
2014-09-18 |
Nestec S.A. |
Composition for use in brain growth and/or cognitive and/or psychomotor development
|
WO2013091660A1
(en)
*
|
2011-12-23 |
2013-06-27 |
Glycom A/S |
A method for obtaining crystalline lacto-n-tetraose and lacto-n-neotetraose precursors and mixtures thereof
|
DE202013012827U1
(de)
*
|
2012-06-14 |
2020-02-13 |
Glycom A/S |
Verbesserung der Stabilität und Reinheit sowie Erhöhung der Bioverfügbarkeit von menschlichen Milch-Oligosacchariden oder Vorläufern oder Mischungen davon
|
ITFI20120143A1
(it)
|
2012-07-12 |
2014-01-13 |
Inalco S A S Di Giovanni Cipollett I & C |
Polimorfi idrati e anidri del 2'-o-fucosillattosio e loro metodi di produzione.
|
DK2708145T3
(en)
|
2012-09-14 |
2016-07-18 |
Abbott Lab |
Nutritional Compositions for Use in Methods to Modulate Corticosterone Levels in Psychologically Stressed Individuals
|
DK2708147T3
(da)
*
|
2012-09-14 |
2020-05-18 |
Abbott Lab |
Fremgangsmåder til forøgelse af hjernefunktionalitet under anvendelse af 2-fucosyl-lactose
|
CN104812768B
(zh)
|
2012-11-13 |
2019-06-21 |
格礼卡姆股份公司 |
晶体3-o-岩藻糖基乳糖
|
ES2891731T3
(es)
|
2013-05-22 |
2022-01-31 |
Glycom As |
Mezcla sintética de oligosacáridos para el tratamiento de la microbiota de un mamífero
|
CN103408609B
(zh)
*
|
2013-09-02 |
2016-01-13 |
济南尚博生物科技有限公司 |
一种制备1-S-2,3,4-三-O-苄基-l-硫代吡喃岩藻糖苷的方法
|
US9902984B2
(en)
|
2013-09-06 |
2018-02-27 |
Glycom A/S |
Fermentative production of oligosaccharides
|
EP2857410A1
(en)
*
|
2013-10-04 |
2015-04-08 |
Jennewein Biotechnologie GmbH |
Process for purification of 2´-fucosyllactose using simulated moving bed chromatography
|
EP2896628B1
(en)
|
2014-01-20 |
2018-09-19 |
Jennewein Biotechnologie GmbH |
Process for efficient purification of neutral human milk oligosaccharides (HMOs) from microbial fermentation
|
CN104098615A
(zh)
*
|
2014-06-09 |
2014-10-15 |
华中科技大学 |
一种以氢氧根离子型的碱为催化剂进行脱酰基化的方法
|
CR20170134A
(es)
|
2014-09-12 |
2017-06-13 |
Basf Se |
Método para preparar 2´-o-fucosil-lactosa
|
CN107108677B
(zh)
|
2014-10-24 |
2020-08-07 |
格礼卡姆股份公司 |
Hmo的混合物
|
US20170258820A1
(en)
|
2014-10-29 |
2017-09-14 |
Glycom A/S |
Synthetic composition and method for promoting mucosal healing
|
US11040049B2
(en)
|
2014-10-29 |
2021-06-22 |
Glycom A/S |
Composition comprising HMSs/HMOs and use thereof
|
CN115364113A
(zh)
|
2014-10-29 |
2022-11-22 |
格礼卡姆股份公司 |
合成组合物以及用于治疗肠易激综合症的方法
|
US11040050B2
(en)
|
2014-10-29 |
2021-06-22 |
Glycom A/S |
Composition comprising HMSs/HMOs and use thereof
|
US10500221B2
(en)
|
2014-12-05 |
2019-12-10 |
Glycom A/S |
Crystalline difucosyllactose
|
US10987368B2
(en)
|
2014-12-08 |
2021-04-27 |
Glycom A/S |
Synthetic composition for preventing or treating CVD
|
US10835544B2
(en)
|
2014-12-08 |
2020-11-17 |
Glycom A/S |
Synthetic composition for regulating satiety
|
CN115350200A
(zh)
|
2014-12-08 |
2022-11-18 |
格礼卡姆股份公司 |
用于治疗代谢障碍的合成组合物
|
US10881674B2
(en)
|
2014-12-08 |
2021-01-05 |
Glycom A/S |
Synthetic composition for treating metabolic disorders
|
EP3265099B1
(en)
|
2015-03-05 |
2023-08-09 |
Glycom A/S |
Human milk oligosaccharides for treating acute respiratory tract infections
|
EP3277287B8
(en)
|
2015-03-31 |
2023-12-27 |
Glycom A/S |
Mixtures of human milk oligosaccharides comprising 3 '-o-sialyllactose
|
ES2870973T3
(es)
|
2015-06-09 |
2021-10-28 |
Glycom As |
Mezclas ternarias de 6'-SL, LNnT y LST c
|
RU2634707C2
(ru)
*
|
2015-07-23 |
2017-11-03 |
Федеральное государственное унитарное предприятие "Государственный научно-исследовательский институт особо чистых биопрепаратов" Федерального медико-биологического агентства |
Способ избирательного удаления О-ацетильных защитных групп в присутствии О-бензоильных
|
PL3349763T3
(pl)
|
2015-09-14 |
2022-01-03 |
Glycom A/S |
Kompozycja do zastosowania w modulowaniu mikrobioty
|
EP3368046B1
(en)
|
2015-10-28 |
2022-07-27 |
Glycom A/S |
Synthetic composition and method for modulating brain function and behaviour
|
ES2950489T3
(es)
|
2015-10-28 |
2023-10-10 |
Glycom As |
Composición sintética y método para modular los trastornos de la emoción y del ánimo
|
WO2017084673A1
(en)
|
2015-11-17 |
2017-05-26 |
Glycom A/S |
Synthetic Composition for Treating Antibiotic Associated Complications
|
US11432578B2
(en)
|
2015-12-15 |
2022-09-06 |
Glycom A/S |
Mixture of HMOs
|
BR112018015833A2
(pt)
*
|
2016-02-03 |
2018-12-26 |
Basf Se |
métodos para preparar 2?-o-fucosil-lactose e produtos alimentícios, composto, e, uso de um dos compostos
|
WO2017144062A1
(en)
|
2016-02-24 |
2017-08-31 |
Glycom A/S |
Synthetic composition for microbiota modulation
|
US20190100547A1
(en)
*
|
2016-03-09 |
2019-04-04 |
Basf Se |
Method for preparing 2'-o-fucosyllactose
|
KR101731263B1
(ko)
|
2016-04-25 |
2017-05-02 |
서울대학교 산학협력단 |
코리네박테리움 글루타미쿰을 이용한 2'-푸코실락토오스의 생산방법
|
PL3452051T3
(pl)
|
2016-05-05 |
2022-11-14 |
Glycom A/S |
Kompozycja zawierająca hmos do zastosowania w leczeniu nadwrażliwości trzewnej i/lub bólu trzewnego mediowanych komórkami tucznymi
|
WO2017190754A1
(en)
|
2016-05-05 |
2017-11-09 |
Glycom A/S |
Composition comprising hmos for the treatment of non-infectious diarrhoea
|
CN105924480B
(zh)
*
|
2016-05-10 |
2018-09-25 |
浙江大学 |
含岩藻糖三糖硫酸酯及其制备方法和应用
|
US11224605B2
(en)
|
2016-05-19 |
2022-01-18 |
Glycom A/S |
Synthetic composition
|
CN109414447A
(zh)
|
2016-06-24 |
2019-03-01 |
格礼卡姆股份公司 |
包括hmo的组合物、其制备和用于预防和/或治疗病毒和/或细菌感染的用途
|
WO2018157900A1
(en)
|
2017-03-01 |
2018-09-07 |
Glycom A/S |
Synthetic composition for microbiota modulation
|
EP3634429A4
(en)
|
2017-05-09 |
2020-11-04 |
Glycom A/S |
SYNTHETIC COMPOSITION FOR MICROBIOTE MODULATION
|
WO2018215961A1
(en)
|
2017-05-24 |
2018-11-29 |
Glycom A/S |
Synthetic composition comprising oligosaccharides and its use in medical treatment.
|
WO2018215960A1
(en)
|
2017-05-24 |
2018-11-29 |
Glycom A/S |
Synthetic composition comprising one or more human milk oligosaccharides (hmos)
|
EP3672600A4
(en)
|
2017-08-21 |
2021-05-19 |
Glycom A/S |
SYNTHETIC COMPOSITION TO REDUCE ALLERGY SYMPTOMS
|
EP3450443A1
(en)
|
2017-08-29 |
2019-03-06 |
Jennewein Biotechnologie GmbH |
Process for purifying sialylated oligosaccharides
|
WO2019071021A2
(en)
|
2017-10-04 |
2019-04-11 |
The Regents Of The University Of California |
IMMUNOMODULATORY OLIGOSACCHARIDES
|
CA3081496A1
(en)
|
2017-11-02 |
2019-05-09 |
Glycom A/S |
Mixture of hmos for reducing or preventing fatigue
|
CN111698994A
(zh)
|
2017-11-30 |
2020-09-22 |
格礼卡姆股份公司 |
治疗小麦敏感性的hmo混合物
|
US11602545B2
(en)
|
2017-12-05 |
2023-03-14 |
Glycom A/S |
Human milk oligosaccharides for treating migraine
|
US11304966B2
(en)
|
2017-12-22 |
2022-04-19 |
Glycom A/S |
Composition comprising HMOs for preventing or reducing nociception
|
CN108084234A
(zh)
*
|
2018-01-23 |
2018-05-29 |
佛山科学技术学院 |
双重随机糖基化合成三糖的方法
|
US11554131B2
(en)
|
2018-05-31 |
2023-01-17 |
Glycom A/S |
Mixture of HMOs for treating autoimmune diseases
|
AU2019362595A1
(en)
|
2018-10-18 |
2021-04-29 |
Basf Se |
Crystalline form II of 2'-O-fucosyllactose, process for its preparation, nutritional, cosmetic or pharmaceutical formulation containing the same
|
CN113194960A
(zh)
|
2018-12-19 |
2021-07-30 |
格礼卡姆股份公司 |
用于治疗使用低fodmap饮食的人的组合物和方法
|
EP3741770A1
(en)
|
2019-05-21 |
2020-11-25 |
Jennewein Biotechnologie GmbH |
Purification of oligosaccharides from a fermentation broth by using filtration
|
CN111588726A
(zh)
*
|
2020-04-28 |
2020-08-28 |
南开大学 |
2′-岩藻糖基乳糖调节宿主肠道菌群及增强肠屏障的应用
|
WO2022223430A1
(en)
|
2021-04-19 |
2022-10-27 |
Dsm Ip Assets B.V. |
A composition of enzymes and human milk oligosaccharides
|
WO2023099297A1
(en)
*
|
2021-12-02 |
2023-06-08 |
Dsm Ip Assets B.V. |
Synthesis of hmo butyrate
|
WO2024013393A1
(en)
|
2022-07-15 |
2024-01-18 |
Dsm Ip Assets B.V. |
Combination of bifidobacterium and fucosylated hmo for use in increasing nmn or nad+
|
WO2024105051A1
(en)
*
|
2022-11-15 |
2024-05-23 |
Ecole Polytechnique Federale De Lausanne (Epfl) |
Method for preparing an at least partially acetal-protected sugar
|